Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy

NCT02844114 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Ganoderma lucidum spore
DRUG: Placebo
DRUG: Chemotherapy

Sponsor

Gao Yajie